Thirteen new procedure codes added to private reimbursement schedule in England

28

Apr 2020

The Clinical Coding and Schedule Development (CCSD) group develops and maintains procedural and diagnostics nomenclature for private payers in England. New procedure codes concern pediatric cataract involving lensectomy with or without lens implant, pediatric cataract involving lens aspiration and implant, delivery of a fraction MR Linac adaptive planned radiotherapy, low-level laser therapy for inflammation/pain relief and others. The codes are introduced with a recommended adoption date being the 1st of May 2020. The documents also contain a list of textual changes in codes and unacceptable combinations.

The CCSD Group approved the following procedure codes for publication to the CCSD Schedule in March 2020 with a recommended adoption date being the 1st of May 2020:

  • Paediatric cataract involving lensectomy without lens implant – unilateral (C7210)
  • Paediatric cataract involving lensectomy without lens implant – bilateral (C7211)
  • Paediatric cataract involving lensectomy with lens implant - unilateral (C7212)
  • Paediatric cataract involving lensectomy with lens implant – bilateral (C7213)
  • Paediatric cataract involving lens aspiration and implant – unilateral (C7214)
  • Paediatric cataract involving lens aspiration and implant – bilateral (C7215)
  • Delivery of a fraction MR Linac adaptive planned radiotherapy, including image guidance (X7019)
  • Planning and preparation for the delivery of MR Linac adaptive planned radiotherapy (X6019)
  • Low-level laser therapy for inflammation/pain relief (F4280)
  • Clinical supervision and planning for delivery of chemotherapy cycle 1 - 56 days (X0005)
  • Diagnostic oesophago-gastro-duodenoscopy (OGD) and immediate flexible sigmoidoscopy includes forceps biopsies, biopsy test and dye spray (as sole procedure) (G8084)
  • Therapeutic oesophago-gastro-duodenoscopy (OGD) and immediate flexible sigmoidoscopy includes forceps biopsies, biopsy test and dye spray (as sole procedure) (G8085)
  • Sub-tenons anaesthesia administered by anaesthetist (as sole procedure) (X3060)

See the full details here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.

The latest related news

21

Mar 2022

The NHS Insights Prioritisation Programme (NIPP) is commissioned by the NHS Accelerated Access Collaborative (AAC) and the National Institute for Health Research (NIHR). It is designed to accelerate the evaluation and implementation of innovation that supports post-pandemic ways of working, builds service resilience, and delivers benefits to patients. Fourteen projects have been funded and have now commenced activity that will be ongoing until March 2023.

Read more

18

Mar 2022

On February 22, 2022, a repository of innovative acts outside the nomenclature of biology and anatomopathology (RIHN) and a Supplementary list of IVD tests were published. Minor changes were introduced in the 2022 RIHN list.

Read more

14

Mar 2022

In February 2021, the Clinical Coding and Schedule Development (CCSD) working group, which develops and maintains procedural and diagnostics nomenclature for private payers in England, published Bulletins 0182 and 0079 with changes to be implemented no later than April 10, 2022. Three new procedure codes concerned robotic surgery in orthopaedic area, spinal procedures, and ophthalmology, and five new diagnostic codes were introduced.

Read more

08

Mar 2022

At the end of February 2022, the Dental and Pharmaceutical Benefits Agency (TLV) has launched a theme survey on products for monitoring and diagnostics of sepsis to identify products that may be relevant for health economic assessments at TLV. The suggestions for the products of interest, ongoing clinical studies, or innovation projects could be received until 23 March 2022.

Read more

07

Mar 2022

On February 08, 2022, the Reimbursement Commission of the Social Security Institution released an updated version of the Healthcare Implementation Communique. The main changes relate to the increase in reimbursement fees of services and medical devices by approximately 35-75%.

Read more